ÂÜÀòÂÒÂ×

A biochemist by training and with a PhD in Structural Biology and Protein Chemistry and an MBA from the Technical University of Munich, Phillip was appointed Chief Scientific Officer of adivo in 2022 after having joined the company in 2019. He combines profound expertise in rational protein design with high throughput protein engineering from his time as a postdoctoral researcher at Brandeis University in Boston, USA.

At adivo, Philipp drives the target identification process and technology development, as well as antibody discovery for both proprietary and partnered programs.